NASDAQ: NEOGNeogen Corp Stock Ownership - Who owns Neogen?
Insider buying vs selling
Have Neogen Corp insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| William T. Boehm | Director | 2023-01-26 | 750 | $20.08 | $15.06kSell |
| William T. Boehm | Director | 2023-01-26 | 1,500 | $15.62 | $23.43kBuy |
| Douglas Edward Jones | Chief Operating Officer | 2023-01-13 | 2,500 | $17.91 | $44.78kBuy |
| Steven J. Quinlan | VP CFO | 2022-10-11 | 5,000 | $11.63 | $58.15kBuy |
| William T. Boehm | Director | 2022-10-03 | 2,000 | $13.89 | $27.77kBuy |
| John Edward Adent | President & CEO | 2022-09-28 | 22,000 | $14.37 | $316.14kBuy |
| Douglas Edward Jones | Chief Operating Officer | 2022-09-28 | 7,000 | $14.31 | $100.17kBuy |
| Darci L. Vetter | Director | 2022-08-16 | 1,100 | $21.83 | $24.01kBuy |
| Ronald D. Green | Director | 2022-08-02 | 1,500 | $22.50 | $33.75kBuy |
| John Edward Adent | President & CEO | 2022-07-29 | 17,500 | $23.07 | $403.73kBuy |
NEOG insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when NEOG insiders and whales buy or sell their stock.
NEOG Shareholders
What type of owners hold Neogen Corp stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Vanguard Group Inc | 8.75% | 18,922,426 | $383.94M | Institution |
| Blackrock Inc | 8.68% | 18,759,359 | $380.63M | Institution |
| Wasatch Advisors Inc | 6.24% | 13,485,361 | $273.62M | Institution |
| Susquehanna International Group LLP | 5.15% | 11,130,072 | $225.83M | Institution |
| Brown Capital Management LLC | 4.04% | 8,739,338 | $177.32M | Institution |
| Select Equity Group LP | 3.76% | 8,120,559 | $164.77M | Institution |
| State Street Corp | 2.57% | 5,563,316 | $112.88M | Institution |
| King Luther Capital Management Corp | 2.05% | 4,440,525 | $90.10M | Institution |
| Conestoga Capital Advisors LLC | 1.91% | 4,132,829 | $83.86M | Institution |
| Bank Of America Corp | 1.83% | 3,963,876 | $80.43M | Institution |
NEOG vs Diagnostic & Research Stocks
Neogen Stock Ownership FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.